↓ Skip to main content
What is this page? Embed badge

Small Molecules in Oncology

Overview of attention for book
Cover of 'Small Molecules in Oncology'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Erlotinib
  3. Altmetric Badge
    Chapter 2 Lapatinib
  4. Altmetric Badge
    Chapter 3 Regorafenib
  5. Altmetric Badge
    Chapter 4 Crizotinib
  6. Altmetric Badge
    Chapter 5 Cabozantinib: Multi-kinase Inhibitor of MET, AXL, RET, and VEGFR2
  7. Altmetric Badge
    Chapter 6 Vemurafenib
  8. Altmetric Badge
    Chapter 7 Trametinib (GSK1120212)
  9. Altmetric Badge
    Chapter 8 Everolimus
  10. Altmetric Badge
    Chapter 9 Vismodegib
  11. Altmetric Badge
    Chapter 10 Larotrectinib (LOXO-101)
  12. Altmetric Badge
    Chapter 11 Palbociclib—The First of a New Class of Cell Cycle Inhibitors
  13. Altmetric Badge
    Chapter 12 Cobimetinib (GDC-0973, XL518)
  14. Altmetric Badge
    Chapter 13 Lenvantinib: A Tyrosine Kinase Inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, KIT and RET
  15. Altmetric Badge
    Chapter 14 Afatinib
  16. Altmetric Badge
    Chapter 15 Olaparib
  17. Altmetric Badge
    Chapter 16 Gefitinib
  18. Altmetric Badge
    Chapter 17 Alectinib
  19. Altmetric Badge
    Chapter 18 Osimertinib
Attention for Chapter 13: Lenvantinib: A Tyrosine Kinase Inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, KIT and RET
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
51 Mendeley
Summary Dimensions citations
So far, Dimensions has found 14 publications that cite this research output.

14

The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.